A 8-week, randomized, double-blind, placebo-controlled human trial to evaluate the efficacy and safety of Saccaharum Officinalis wax alcohols(Policosanol) on improvement of blood cholesterol

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0006606

Enrollment

Registered

2021-09-27

Start date

2021-05-03

Completion date

Unknown

Last updated

2021-10-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Dietary Supplement : • Saccaharum Officinalis wax alcohols(Policosanol) group: Once a day, 1 tablet once, after meal, for 8 weeks{330 mg/day, 20 mg/day for Saccaharum Officinalis wax alcohols(Policosa

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Males and females aged over 19 years and under 75 years at the screening examination 2) 100 =Fasting LDL-cholesterol(mg/dL) =159 3) Participants who have fully understand the information provided about the study voluntarily decided to participate and agree to comply with precautions

Exclusion criteria

Exclusion criteria: 1) Participants with a history of antipsychotic medication use within 3 months prior to the screening examination. 2) Patients with a history of medicine or alcohol abuse 3) Patients who have participated in other clinical trials within 3 months prior to the screening examination

Design outcomes

Primary

Measure	Time frame
Low-density-lipoprotein-cholesterol	—

Secondary

Measure	Time frame
Triglyceride;High density lipoprotein-cholesterol	—

Countries

Korea, Republic of

Contacts

Public ContactJeonghan Lee

Wonkwang University. Iksan Korean Medicine Hospital

milpaso@wku.ac.kr+82-63-859-2807

Outcome results